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Background: In 1985, a bat researcher in Finland died of rabies encephalitis caused by European bat lyssavirus type
2 (EBLV-2), but an epidemiological study in 1986 did not reveal EBLV-infected bats. In 2009, an EBLV-2-positive
Daubenton’s bat was detected. The EBLV-2 isolate from the human case in 1985 and the isolate from the bat in
2009 were genetically closely related. In order to assess the prevalence of EBLVs in Finnish bat populations and to
gain a better understanding of the public health risk that EBLV-infected bats pose, a targeted active surveillance
project was initiated.
Results: Altogether, 1156 bats of seven species were examined for lyssaviruses in Finland during a 28–year period
(1985–2012), 898 in active surveillance and 258 in passive surveillance, with only one positive finding of EBLV-2 in a
Daubenton’s bat in 2009. In 2010–2011, saliva samples from 774 bats of seven species were analyzed for EBLV viral
RNA, and sera from 423 bats were analyzed for the presence of bat lyssavirus antibodies. Antibodies were detected
in Daubenton’s bats in samples collected from two locations in 2010 and from one location in 2011. All seropositive
locations are in close proximity to the place where the EBLV-2 positive Daubenton’s bat was found in 2009. In
active surveillance, no EBLV viral RNA was detected.
Conclusions: These data suggest that EBLV-2 may circulate in Finland, even though the seroprevalence is low. Our
results indicate that passive surveillance of dead or sick bats is a relevant means examine the occurrence of
lyssavirus infection, but the number of bats submitted for laboratory analysis should be higher in order to obtain
reliable information on the lyssavirus situation in the country.
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Rabies is a viral zoonosis that causes fatal encephalitis
in mammals. The Lyssavirus genus includes 12 recog-
nized species also referred to as genotypes: classical ra-
bies virus (RABV), Lagos bat virus (LBV), Mokola virus
(MOKV), Duvenhage virus (DUVV), European bat
lyssavirus type 1 (EBLV-1), European bat lyssavirus type
2 (EBLV-2), Australian bat lyssavirus (ABLV), Irkut virus
(IRKV), West Caucasian bat virus (WCBV), Khujand virus
(KHUV) and Aravan virus (ARAV) [1]. Shimoni bat virus
(SHBV) was recently ratified by the International Commit-
tee on Virus Taxonomy [2]. Furthermore, novel lyssa-
viruses have been detected in a Natterer’s bat in Germany,
named as Bokeloh Bat Lyssavirus (BBLV) [3], which has
subsequently also been found in France [4], and Ikoma* Correspondence: Tiina.Nokireki@evira.fi
1Finnish Food Safety Authority Evira, Mustialankatu 3, Helsinki FI-00790,
Finland
Full list of author information is available at the end of the article
© 2013 Nokireki et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
waiver (http://creativecommons.org/publicdom
stated.Lyssavirus (IKOV) in an African civet (Civettictis civetta)
[5]. A new tentative lyssavirus, Lleida bat lyssavirus
(LLEBV), was found in a bent-winged bat (Miniopterus
schreibersii) in Spain [6].
Since the first case of bat rabies in Germany in 1954,
1040 cases of rabid bats have been reported in Europe
[7]. There have been about 20 cases of EBLV-2, which
have occurred in five countries: Switzerland [8], the
Netherlands [9], the UK [10,11], Germany [12] and
Finland [13]. EBLV-2 is typically detected in Daubenton’s
bat (Myotis daubentonii) and the pond bat (M. dasycneme),
whereas the vast majority of EBLV-1 detections have
been from the Serotine bat (Eptesicus serotinus) [7].
Spill-over infections have been described for EBLV-1 in
a stone marten (Martes foina) [14], sheep [15] and
domestic cats [16]. Selimov et al. reported a human case
associated with a bat in Russia in 1985. This virus was
later shown to be EBLV-1 [17]. Two cases of EBLV-2
infection in humans, both in individuals working withl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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and one in the UK in 2002 [19].
In the UK, EBLV-2 has been isolated from Daubenton’s
bats eight times [20]. In 2003, in a targeted surveillance of
Daubenton’s bats, a seroprevalence of 0.05% to 3.8% was
detected. However, the virus was not detected from the
218 swabs tested [20]. A study from 2003 to 2006 revealed
a seroprevalence of 1.0% to 4.1% [21].
In Switzerland, three out of 837 brains examined be-
tween 1976 and 2009 were found to be positive for EBLV-
2. In targeted active surveillance in 2009, one oral swab
from a Daubenton’s bat out of 237 bats swabbed was posi-
tive for EBLV-2 and three bats were seropositive [22]. InTable 1 Summary of lyssavirus surveillance focusing on Daub
Country No. of bats in
active
surveillance
(No. of
positive bats)
No. of
Daubenton's bats
in active
surveillance (No.
of positive bats)
No. of bats in
passive
surveillance
(No. of positive
bats)
No.
bat
sur
pos
Finland 774 (0) 399 (0) 199 (1) 8 (1
124 (0) 69 (0) 59 (0) 2 (0
Germany 45 (
~1800 (187)
65 (1)
Netherlands 3873 (256) 111
UK 7457 (6) 144
766 (0) 439 (0)
218 (0) 198 (0)
< 900 (1) > 900 (1)
Sweden 78 (0) 1 (0
Switzerland 237 (1) 148 (1) 837 (3) 64 (Germany, 1800 bats were tested between 1997 and 2007,
out of which 45 were Daubenton’s bats and one a pond
bat. EBLV-2 was isolated in Germany twice, first in 2007
[12] and then again in 2012 [23]. In the Netherlands, 129
suspected pond bats were analyzed and 5 were found to
be positive for EBLV-2, resulting in a prevalence of 3.9%
[9]. (Table 1). In the area of the Former Soviet Union, more
than 3000 bats were analyzed for rabies during 1964–2004
and five lyssavirus species were recorded [24]. Virus-
neutralizing antibodies have been found in a number of
bat species in several European countries, but because of
cross-reactivity, seropositivity cannot be linked to a spe-
cific lyssavirus [25]. Eight Daubenton’s bats sampled inenton’s bats in different European countries
of Daubenton's
s in passive
veillance (No. of
itive bats)
No. of bats in
serosurveillance
(No. of positive
bats)
No. of
Daubenton's bats
in
serosurveillance
(No. of positive
bats)
Reference
) 423 (3 – 9) 268 (3 – 9) This paper,
Jakava-
Viljanen
et al. 2010
[13]
) Hagner
et al. 1986
[27]
1) Freuling
et al. 2008
[12]
Müller et al.
2007 [28]
Freuling
et al. 2011
[3]
98 (5) Schatz et al.
2013 [25]
(0) van der
Poel et al.
2005 [9]
(6) Harris et al.
2007 [10]
660 (5 – 16) 363 (4 – 15) Harris et al.
2009 [21]
224 (6 – 18) 198 (6 – 18) Brookes
et al. 2005
[20]
> 900 ~ 27 SNH,
reviewed in
Schatz et al.
2012 [23]
) 124 (8) 77 (8) SVA 2009,
reviewed in
Schatz et al.
2012 [23]
3) 202 (3) 124 (3) Megali et al.
2010 [22]
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EBLV-1 as the antigen [26]. Seropositive Daubenton’s bats
have also been found in the UK and Switzerland [25].
To date, thirteen species of bats have been recorded
in Finland out of 45 species present in Europe [29]. All
of them, apart from the Northern bat (Eptesicus
nilssonii), are at the northern-most limit of their range,
and most of the species are restricted to southern and
central Finland. Only five species are common in
Finland; the rest are either very rare or only a few indi-
viduals have been recorded so far (Table 2) [30]. The
vast majority of the Finnish bats are small, weighing c.
10 g, and insectivorous. Despite an epidemiological
study in Finland in 1986 of 183 bats, 124 of which were
actively sampled and 59 dead, injured or abnormally be-
having [27], and subsequent passive rabies surveillance,
rabies in bats was not detected in the country until a
case in a Daubenton’s bat was confirmed in autumn
2009. Phylogenetic analysis revealed that the EBLV-2
isolate from the human case in 1985 and the isolate
from the bat in 2009 were genetically closely related,
demonstrating that EBLV-2 may have been circulating
in Finland for years [13].
In this study we assessed the prevalence of EBLVs in
Finnish bat populations in order to gain a better under-
standing of the public health risk that EBLV-infected
bats pose. In 2010, a targeted active surveillance project
was initiated by the Finnish Food Safety Authority Evira
together with the University of Turku and the Finnish
Museum of Natural History (University of Helsinki).
The active sampling was focused on Southwest Finland,
in the area where the EBLV-2 positive bat was found in
2009, and on Uusimaa, in the area where the deceased
bat researcher had worked in 1985.Table 2 Status and distribution of the bat species recorded in
Species
Nyctalus noctula
Eptesicus nilssonii
Eptesicus serotinus
Vespertilio murinus
Plecotus auritus
Pipistrellus nathusii
Pipistrellus pipistrellus
Pipistrellus pygmaeus
Myotis nattereri
Myotis brandtii
Myotis mystacinus
Myotis daubentonii
Myotis dasycneme
Status categories for red list species are based on Liukko et al. [31].Results
From the passive surveillance of 258 samples (Table 3),
all samples were negative, except for one positive
Daubenton’s bat in 2009. This positive case has been
reported earlier [13].
Serum was analyzed from 423 bats of six species in 167
pools (Table 4). Blood samples were collected from 275
and 148 bats in 2010 and 2011, respectively. Antibodies
were detected from Daubenton’s bats from two sampling
sites in 2010 in the city of Turku (60°27′05″N, 022°16′
00″E) and in Nauvo (60°11′35″N, 21°54′25″E), and from
one sampling site in 2011 from the city of Naantali (60°
28′05″N, 22°01′35″E). All the positive sites were from the
same geographical area (Figure 1). The positive samples
were from 3 to 9 individuals due to the pooling of samples.
All seropositive bats were males. In the pool collected in
2010 from Turku, all individuals were adults and caught
while flying. In the pool collected in Nauvo, all bats were
adults and they were caught in roosts. In the seropositive
pool collected in 2011 from Naantali, one individual was
an adult and two were juveniles, and they were caught
while flying. Altogether, 268 samples from Daubenton’s
bat were analyzed, resulting in a seroprevalence of 1.12%
to 3.36%. A 95% confidence interval for the true preva-
lence of 0.2–4% was calculated, as described by Rogan and
Gladen [32]. No EBLV RNA was detected in any of the
oropharyngeal swabs analyzed (Table 4).
Discussion
A working group of the European research consortium
Med-Vet-Net has established guidelines on passive and
active bat rabies surveillance. This scheme was also
adopted in EUROBATS Resolution 5.2 and in a scientific
report submitted to the European Food Safety AuthorityFinland, modified from Kyheröinen et al. [30]
Distribution/status
Rare, S Finland, migrant
Common, widespread, to S Lapland, some records even further north
Only a few records, S Finland (first record 2008)
Rare, S Finland, migrant
Common, widespread, S & Central Finland, to circa 64° N lat.
Restricted, S Finland, migrant/vulnerable
Rare, S Finland, migrant (first record 2001)
Rare, S Finland, migrant (first record 2007)
Rare, S Finland/ endangered
Common, widespread, S & Central Finland, to circa 66° N lat.
Common, widespread, S & Central Finland, to circa 66° N lat.
Common, widespread, S & Central Finland, to 66° N lat.
Only a few records, E Finland (first record 2002)
Table 3 Number of bats tested for rabies in passive surveillance during 1985–2012
Year Unknown/N.A. Eptesicus
nilssonii
Myotis
daubentonii
Myotis
mystacinus
Myotis
brandtii
Plecotus
auritus
In
total
Number of positive
samples
2012 8 16 1 6 1 32 0
2011 3 6 4 13 0
2010 6 1 1 8 0
2009 4 13 3 2 2 24 1
2008 0 0
2007 1 2 3 0
2006 1 1 0
2005 1 1 0
2004 1 2 1 4 0
2003 1 1 0
2002 3 3 0
2001 1 1 0
2000 2 2 0
1999 2 2 0
1998 9 9 0
1997 1 1 0
1996 5 5 0
1995 5 5 0
1994 2 2 0
1993 1 1 2 0
1992 3 6 1 3 1 14 0
1991 5 5 0
1990 4 3 7 0
1989 3 3 6 0
1988 13 13 0
1987 35 35 0
1986 3 33 2 1 8 14 61 0
1985 1 1 0
In
total
100 105 10 19 8 19 261 1
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lyssaviruses varies considerably between European coun-
tries, as reviewed by Schatz et al. [25]. In Finland, an active
surveillance project was initiated in order to complement
passive surveillance after the first EBLV-2 virus detection
in a bat in 2009. We demonstrated that EBLV-2 appears to
be endemic in Finland in the studied area.
Passive surveillance of bat rabies might be a sufficient
and relevant means for obtaining information on its occur-
rence in Finland. However, the number of bats included in
passive surveillance needs to be higher than during 1985–
2012, and means to obtain more samples should be consid-
ered. In particular, more Daubenton’s bat samples should
be tested, as it has been shown that there is a significant
correlation between the number of positive bats and thenumber of bats examined. Thus, it appears that infected
bats are more likely to be sampled [34]. Daubenton’s bats
do not usually roost in buildings, reducing the likelihood of
property owners finding grounded bats. This might lead to
lower passive sampling of this species. Specimens of
Daubenton’s bats sent by the public to natural history mu-
seums and to laboratories are less numerous compared to
species such as Brandt’s bats (M. brandtii) or Northern
bats (E. nilssonii), which commonly roost in house attics or
other sheltered structures in buildings. It has been demon-
strated that most positive samples are detected in the third
quarter of the year [25]. In Finland, passive surveillance
samples are mostly sent between July and September.
Active sampling of oral swabs has rarely resulted in posi-
tive findings, and our findings are consistent with this.
Table 4 Number of bats tested for cross-neutralizing lyssavirus antibodies and viral EBLV-1 and −2 per species and
number of positive bats during active sampling in 2010 and 2011
Species Number of bats (number of positive bats) tested for
lyssavirus antibodies
Number of bats (number of positive bats) tested
for EBLV-1 and −2 RNA
M. daubentonii 268 (3 - 9*) 399 (0)
M. brandtii 71 (0) 129 (0)
P. auritus 38 (0) 98 (0)
E. nilssonii 29 (0) 108 (0)
M. mystacinus 16 (0) 36 (0)
M. nattereri 1 (0) 1 (0)
P. nathusii 0 3 (0)
Total 423 (3 - 9*) 774 (0)
* Pooled samples.
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samples in Switzerland, with only one EBLV-2 viral RNA
positive Daubenton’s bat being found in each country. In
Spain, 49 E. isabellinus samples out of 1297 samples ana-
lyzed were positive for EBLV-1 [25]. New lyssaviruses have
been found when many bats have been killed for surveil-
lance purposes [24], but invasive sampling is prohibited in
Europe according to Council Directive 92/43/EEC on the
conservation of natural habitats and of wild fauna and
flora (94/43/EEC) and the Agreement on the conservation
of populations of European bats.
Serological testing can be used as an indicator of past
exposure to lyssavirus in bats. Seropositive Daubenton’s
bats have been recorded in the UK, Switzerland, Sweden
(reviewed in Schatz et al. 2012 [25]), and now inFigure 1 Map showing the sampling locations of bats in Finland duri
Seropositive locations are marked with •.Finland. Results from our surveillance indicate that the
seroprevalence of antibodies against bat lyssaviruses in
the Finnish bat population is low. All seropositive sam-
pling sites exhibit high Daubenton’s bat densities. The
samples also represent individuals of the same large
population, with high frequencies of gene flow between
individuals of separate sampling sites [35]. The sero-
prevalence in bats of antibodies presumably against
EBLV-2 has been low, as in our study. However, the
seroprevalence of antibodies against RABV in New
World bats and against EBLV-1 in Spain have been rela-
tively high (reviewed in Franka et al. 2008 [36]). In an
experimental infection, none of the Daubenton’s bats
infected with EBLV-2 seroconverted [37]. On the other
hand, in an experimental infection of North American big150 km 
ng the active surveillance project in 2010 and 2011 (+).
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dermal infection. Seroconversion appears to depend on
the viral dose, bat species, route of exposure and the
lyssavirus species infecting the bats [36]. The results of
serosurveillance are not fully comparable because of dif-
ferences in methods and antigens used, as well as in
threshold values. Using a reciprocal titer of 27 or more as
a positive cut-off level may underestimate the actual num-
ber of EBLV-seropositive bats, especially when samples
have been pooled. Furthermore, reducing the cut-off value
of a serological assay results in an increase in sensitivity
but a decrease in specificity.
The health risk to the general public, which has no con-
tact with bats through work or leisure, is considered negli-
gible. However, resident bat species in Finland can be
infected not only with EBLV-2 but also with other
lyssaviruses, including lyssaviruses that have not yet been
identified. The most common bat species in Finland is the
northern bat (Eptesicus nilssonii), which has not been as-
sociated with lyssavirus infections. Only a few observa-
tions of the species E. serotinus have so far been recorded
in Finland since the first specimen found in 2008. Myotis
dasycneme and M. nattereri are also very rare in Finland.
The distribution ranges of bats in Finland are still poorly
known due to the limited number of bat studies carried
out in the country.
Positive lyssavirus findings in Finland are from
Daubenton’s bat. Daubenton’s bat is a small, widespread
and common Eurasian bat species. It is considered a fac-
ultative seasonal migrant, covering middle-range dis-
tances between summer and winter roosts, often within
a distance of 100–150 km [38]. Studies have demon-
strated that females, in particular, change their roost
relatively often, usually after a few days [39]. Factors that
could enhance the maintenance of EBLVs in bat popula-
tions include the mobility of many bat species, allowing
a high level of gene flow. Laine et al. [35] observed no
population structuring in a study of specimens from a
broad geographical range in southern Finland and the
United Kingdom, Spain and Switzerland. Daubenton’s
bats, like many other species of the Myotis genus, live in
fusion-fission colonies, where all the individual bats in
the same roosting area form a loose colony, although no
two individuals spend all their time together [40]. The
fused colony is formed of a number of subgroups, be-
cause it is most likely that an entire colony is comprised
of more bats than could fit into a single roost. Fission
occurs during roost switching, when subgroups break
apart and mix, with the bats ending up in different
roosts [41]. This allows bats to expand their social net-
work and effectively increase their colony size without
all colony members occupying the same roost. This has
many ecological advantages, but also facilitates the ef-
fective spread of disease in an extended colony.Conclusions
We demonstrated that bat lyssavirus infection appears to
be endemic in the studied area in Finland. Passive sur-
veillance of bat rabies might be a sufficient and relevant
means for obtaining information on the occurrence of
bat rabies in the country. Results from our active sur-
veillance in 2010 and 2011, earlier active surveillance in
1986 and ongoing passive surveillance indicate that the
prevalence of EBLV in the Finnish bat population is low.
The numbers of bats submitted in passive surveillance
should, however, be higher, and means to obtain more
samples should be considered. In Finland, the health risk
to the general public, which has no contact with bats
through work or leisure, is still considered negligible.
Methods
Passive surveillance
Dead bats or bats showing clinical signs were submitted
by veterinarians, members of the public, animal shelters
and bat biologists. The number of bats tested during
1985–2012 was 258, and details are presented in Table 3.
Active surveillance
Ethical approval and permission
The National Animal Experiment Board of the County
Administrative Board of Southern Finland approved the
sampling of bats, including blood and saliva sampling (per-
mit numbers: Lilley ESLH-YM-2007-01055, Kyheröinen
ESLH-2009-04958/Ym-23), which followed Finnish legisla-
tion, namely the Finnish Act on the Use of Animals for
Experimental Purposes (62/2006). Bats were captured and
handled under permits from regional environmental
centers (Centre for Economic Development, Transport
and the Environment): Southeast region, KASELY/379/20/
07.01/2010; Southern Finland, LUO 459/UUS-2009-L-
388-254 and UUDELY/475/07.01/2011; Southwest region,
LOS-2007-L-182-254; Eastern region, POSELY/501/07.01/
2010 and ESAELY/557/07.01/2010.
Active surveillance took place in 2010 and in 2011,
most of the bats being sampled for saliva and serum
during the summers of 2010 and 2011. Individuals of
seven bat species (Table 4) were caught from 71 sam-
pling sites using a combination of harp traps and mist
nets placed across woodland corridors, which bats use
to commute to foraging areas at dusk, and across for-
aging sites such as river banks. On some occasions, cap-
ture took place near the roost in a building. A Sussex
Autobat acoustic lure, placed in front of a harp trap, was
used to attract bats to the site [42]. Bats were also
caught from bat boxes that had been monitored for sev-
eral years. Altogether, 190 bats were sampled from
roosts and 584 bats were caught while flying.
In some cases, captured bats were fitted with radio
transmitters (Holohil LB-2) in order to follow them to the
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marily sampled, located in bird boxes or abandoned wood-
pecker cavities. This enabled the sampling of the whole
roost, either directly by taking the bats from the opened
nest box or by placing a small mist net in front of the
woodpecker cavity opening and waiting for the bats to
vacate the roost at dusk. At a single site, Daubenton’s bats
were sampled from the ceiling of an old mill.
Care was taken to only handle the bats with gloves
thick enough to prevent penetration if bitten. All sam-
pled bats were identified to species, gender was recorded
and the age category (juvenile, subadult or adult) was
determined from the calcification of the digit joints.
Forearms were measured and the individuals were
weighed. Saliva and blood samples were subsequently
collected. The species distribution and respective sample
numbers are presented in Table 4. Most of the samples
were taken in southern Finland, in the coastal area ran-
ging from Hamina (near the Russian border) in the east
to the Turku Archipelago in the west (Figure 1).
Saliva samples were collected from 459 and 315 bats
in 2010 and 2011, respectively. The specimens were col-
lected from the oral cavity and oropharynx using dry
nylon fiber- tipped oral swabs (Copan) and transported
in a Copan Universal Transport Medium (UTM-RT)
System (Copan Diagnostics Inc.). They were kept frozen
until laboratory analysis.
Blood samples were collected into a single 75-μl capil-
lary tube from the interfemoral vein after lancing with a
27-gauge needle. The capillary tubes were centrifuged
and the hematocrit was measured with a caliper. Serum
for rabies antibody screening was stored in Eppendorf
tubes, which were kept frozen at −20°C until laboratory
analysis.
Analysis of the samples
Routine rabies laboratory diagnosis was performed on
brain samples from passive surveillance according to
the OIE Manual of Standards for Diagnostic Tests and
Vaccines, 2009 [43], using a standard fluorescent anti-
body test (FAT). Two conjugates were used: rabies
conjugate anti-nucleocapsid (Bio-Rad, USA) and FITC
anti-rabies monoclonal globulin (Fujirebio Diagnostics
Inc., USA). Conjugates were diluted according to the
manufacturers’ instructions.
The RNA for PCR studies was extracted from oral swabs
with a QIAamp Viral RNA Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
RNA was tested for EBLV-1 and EBLV-2 with the OneStep
real-time reverse transcription-polymerase chain reaction
(OneStep RT-PCR kit, Qiagen, Hilden, Germany) test. The
reaction volume was 50 μl and the temperature profile of
cDNA synthesis and amplification was: 50°C for 30 min,
95°C for 15 min and 45 cycles of 95°C for 30 s, 52°C for30 s, and 72°C for 20 s. The primer (JW12, N165-146)
and the probe (LysGT5 and LysGT6) sequences were
published by Wakeley et al. 2005 [44].
Serological testing for EBLV virus neutralizing anti-
bodies was performed using a fluorescent antibody virus
neutralization test [45] according to modification
(mFAVN) by the UK Animal Health and Veterinary La-
boratories Agency (AHVLA). The volume of sera used
was 30 μl. The EBLV-2 antigen, strain RV 628, was pro-
vided by the European Virus Archive supported by the
European Community. Two positive control sera, both
provided by the European Virus Archive, were used in
each test. Samples often needed to be pooled to obtain the
minimum serum volume required for the test. In total,
167 pools were tested. Pooled samples were from animals
of the same species, gender and site. Samples were ana-
lyzed in duplicate and serially diluted using a 3-fold series.
A threshold of 1:27 was chosen to distinguish positive
from negative samples.
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